We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| HSBC Holdings PLC | NYSE:HSBC | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.135 | 0.30% | 44.565 | 44.60 | 44.32 | 44.37 | 308,651 | 16:22:03 |
From May 2019 to May 2024
By Adria Calatayud
GlaxoSmithKline PLC (GSK.LN) said Wednesday that Jonathan Symonds, currently deputy chairman of HSBC Holdings PLC (HSBA.LN), will succeed Philip Hampton as nonexecutive chairman with effect from Sept. 1.
Mr. Symonds is a former chief financial officer of Novartis AG (NOVN.EB) and AstraZeneca PLC (AZN.LN), the FTSE 100-listed pharmaceutical company said. He is currently nonexecutive chairman of Proteus Digital Health Inc., a nonexecutive director of Rubius Therapeutics Inc. (RUBY) and chairman of Genomics England Ltd., the company said.
GlaxoSmithKline is due to report second-quarter earnings later on Wednesday.
Write to Adria Calatayud at adria.calatayudvaello@dowjones.com
(END) Dow Jones Newswires
July 24, 2019 05:25 ET (09:25 GMT)
Copyright (c) 2019 Dow Jones & Company, Inc.
1 Year HSBC Chart |
1 Month HSBC Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
